גאלבוס 50 מ"ג

Kraj: Izrael

Język: hebrajski

Źródło: Ministry of Health

Składnik aktywny:

VILDAGLIPTIN 50 MG

Dostępny od:

NOVARTIS PHARMA SERVICES AG

Kod ATC:

A10BH02

Forma farmaceutyczna:

TABLETS

Droga podania:

PER OS

Wyprodukowano przez:

NOVARTIS PHARMA STEIN AG, SWITZERLAND

Grupa terapeutyczna:

VILDAGLIPTIN

Wskazania:

Galvus is indicated as an adjunct to diet and exercise in patients with type 2 diabetes mellitus• As monotherapy, if diet and exercise are not sufficient, or• In combination with metformin, or a sulfonylurea if treatment with these oral antidiabetics does not offer sufficient control of blood glucose.As triple oral therapy in combination with• a sulphonylurea and metformin when diet and exercise plus dual therapy with these agents do not provide adequate glycaemic control. Galvus is also indicated for use in combination with insulin (with or without metformin) when diet and exercise plus a stable dose of insulin do not provide adequate glycaemic control.

Data autoryzacji:

2008-12-01